CoChat

The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop

Open access
Guerriero, Carla, Cairns, John, Roberts, Ian, Rodgers, Anthony, Whittaker, Robyn, Free, Caroline · 2013 · The European Journal of Health Economics
Cited by 152

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The txt2stop trial has shown that mobile-phone-based smoking cessation support doubles biochemically validated quitting at 6 months. This study examines the cost-effectiveness of smoking cessation support delivered by mobile phone text messaging. METHODS: The lifetime incremental costs and benefits of adding text-based support to current practice are estimated from a UK NHS perspective using a Markov model. The cost-effectiveness was measured in terms of cost per quitter, cost per life year gained and cost per QALY gained. As in previous studies, smokers are assumed to face a higher risk of experiencing the following five diseases: lung cancer, stroke, myocardial infarction, chronic obstructive pulmonary disease, and coronary heart disease (i.e. the main fatal or disabling, but by no means the only, adverse effects of prolonged smoking). The treatment costs and health state values associated with these diseases were identified from the literature. The analysis was based on the age and gender distribution observed in the txt2stop trial. Effectiveness and cost parameters were varied in deterministic sensitivity analyses, and a probabilistic sensitivity analysis was also performed. FINDINGS: The cost of text-based support per 1,000 enrolled smokers is £16,120, which, given an estimated 58 additional quitters at 6 months, equates to £278 per quitter. However, when the future NHS costs saved (as a result of reduced smoking) are included, text-based support would be cost saving. It is estimated that 18 LYs are gained per 1,000 smokers (0.3 LYs per quitter) receiving text-based support, and 29 QALYs are gained (0.5 QALYs per quitter). The deterministic sensitivity analysis indicated that changes in individual model parameters did not alter the conclusion that this is a cost-effective intervention. Similarly, the probabilistic sensitivity analysis indicated a >90 % chance that the intervention will be cost saving. INTERPRETATION: This study shows that under a wide variety of conditions, personalised smoking cessation advice and support by mobile phone message is both beneficial for health and cost saving to a health system.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10198-012-0424-5

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 18

  1. Newman, A.B., Brach, J.S.: Gender gap in longevity and disability in older persons. Epidemiol. Rev. 23, 343–355 (2001) · DOI · Paper page
  2. Stapleton, J.: Cigarette smoking prevalence, cessation and relapse. Stat. Methods Med. Res. 7, 187–203 (1998) · DOI
  3. Etter, J.F., Stapleton, J.A.: Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tob. Control 15, 280–285 (2006) · DOI · Paper page
  4. Craig, F., Hirani, V. (eds.): Health survey for England, 2009. The NHS Information Centre (2010)
  5. Forman, D., Stockton, D., Moller, H., Quinn, M., Babb, P., De Angelis, R., Micheli, A.: Cancer prevalence in the UK: results from the EUROPREVAL study. Ann. Oncol. 14, 648–654 (2003) · DOI
  6. Britton, M.: The burden of COPD in the U.K.: results from the Confronting COPD survey. Respir. Med. 97(Suppl C), S71–S79 (2003) · DOI · Paper page
  7. Peto, R., Darby, S., Deo, H., Silcocks, P., Whitley, E., Doll, R.: Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321, 323–329 (2000) · DOI · Paper page
  8. Tengs, T.O., Wallace, A.: One thousand health-related quality-of-life estimates. Med. Care 38, 583–637 (2000) · DOI · Paper page
  9. Rutten-van Molken, M.P., Oostenbrink, J.B., Tashkin, D.P., Burkhart, D., Monz, B.U.: Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 130, 1117–1128 (2006) · DOI · Paper page
  10. Tillmann, M., Silcock, J.: A comparison of smokers’ and ex-smokers’ health-related quality of life. J. Pub. Health Med. 19, 268–273 (1997) · DOI
  11. McGhan, W.F., Smith, M.D.: Pharmacoeconomic analysis of smoking-cessation interventions. Am. J. Health-Syst. Pharm. 53, 45–52 (1996) · DOI
  12. Yudkin, P., Hey, K., Roberts, S., Welch, S., Murphy, M., Walton, R.: Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch. BMJ 327, 28–29 (2003) · DOI · Paper page
  13. Briggs, A., Claxton, K., Sculpher, M.: Decision modelling for health economic evaluation. In: Handbook in Economic Evaluation, Oxford University Press, Oxford (2008)
  14. Flack, S., Taylor, M., Trueman, P.: A rapid review of the cost-effectiveness of National Health Service treatments for smoking cessation in England. York Health Economics Consortium (2006)
  15. Arday, D.R., Giovino, G.A., Schulman, J., Nelson, D.E., Mowery, P., Samet, J.M.: Cigarette smoking and self-reported health problems among U.S. high school seniors, 1982–1989. Am. J. Health Promot. 10, 111–116 (1995) · DOI · Paper page
  16. van Baal, P.H., Polder, J.J., de Wit, G.A., Hoogenveen, R.T., Feenstra, T.L., Boshuizen, H.C., Engelfriet, P.M., Brouwer, W.B.: Lifetime medical costs of obesity: prevention no cure for increasing health expenditure. PLoS Med. 5, e29 (2008) · DOI · Paper page
  17. Woolacott, N.F., Jones, L., Forbes, C.A., Mather, L.C., Sowden, A.J., Song, F.J., Raftery, J.P., Aveyard, P.N., Hyde, C.J., Barton, P.M.: The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol. Assess. 6, 1–245 (2002) · DOI · Paper page
  18. Feenstra, T.L., Hamberg-van Reenen, H.H., Hoogenveen, R.T., Rutten-van Molken, M.P.: Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value Health 8, 178–190 (2005) · DOI

Cited by

See all 152

Metadata

Authors
Guerriero, C., Cairns, J., Roberts, I., Rodgers, A., Whittaker, R., & Free, C.
Venue
The European Journal of Health Economics
Published
2012-09-09
Volume
14
Issue
5
Pages
789-797
ISSN
  • 1439-3972 (ISSN-L)
  • 1618-7598
  • 1618-7601
OpenAlex
W2158036860
Cited by
152
References
4
FWCI
3.59
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop. https://app.cochat.ai/papers/10.1007/s10198-012-0424-5
The paper
Guerriero, C., Cairns, J., Roberts, I., Rodgers, A., Whittaker, R., & Free, C. (2013). The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop. The European Journal of Health Economics. https://doi.org/10.1007/s10198-012-0424-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.